Cargando…

Polymorphism of Angiotensin-Converting Enzyme (rs4340) and Diabetic Nephropathy in Caucasians with Type 2 Diabetes Mellitus

Diabetic nephropathy (DN) is the leading cause of endstage renal disease (ESRD) in developed countries. Several environmental and genetic factors predict the development and progression of DN. The renin-angiotensin system was demonstrated to be involved in the development of DN. We evaluated the ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Šeruga, M, Makuc, J, Završnik, M, Cilenšek, I, Ekart, R, Petrovič, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343328/ https://www.ncbi.nlm.nih.gov/pubmed/28289586 http://dx.doi.org/10.1515/bjmg-2016-0033

Ejemplares similares

PECAM-1 Leu125Val (rs688) Polymorphism and Diabetic Nephropathy in Caucasians with Type 2 Diabetes Mellitus
por: Završnik, Matej, et al.
Publicado: (2016)

Sirtuin 1 rs7069102 polymorphism is associated with diabetic nephropathy in patients with type 2 diabetes mellitus
por: Letonja, Jernej, et al.
Publicado: (2021)

SLC22A3 rs2048327 Polymorphism Is Associated with Diabetic Retinopathy in Caucasians with Type 2 Diabetes Mellitus
por: Grbić, Emin, et al.
Publicado: (2023)

The angiotensin‐converting enzyme insertion/deletion polymorphism rs4340 associates with habitual physical activity among European American adults
por: Bruneau, Michael, et al.
Publicado: (2017)

Angiotensin converting enzyme gene polymorphism in type II diabetics with nephropathy
por: Naresh, V. V. S., et al.
Publicado: (2009)

Angiotensin converting enzyme gene polymorphism in type 2 diabetics with nephropathy
por: Naresh, V. V. S., et al.
Publicado: (2010)

Manganese Superoxide Dismutase Gene Polymorphism (V16A) is Associated with Diabetic Retinopathy in Slovene (Caucasians) Type 2 Diabetes Patients
por: Petrovič, Mojca Globočnik, et al.
Publicado: (2008)

A review of urinary angiotensin converting enzyme 2 in diabetes and diabetic nephropathy
por: Gilbert, Akankwasa, et al.
Publicado: (2018)

Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients
por: Aggarwal, Neerja, et al.
Publicado: (2017)

A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy
por: Pathak, Jahnavi V., et al.
Publicado: (2015)

2 year followup of patients with diabetes mellitus nephropathy showing albuminuria reversal following angiotensin converting enzyme inhibitors
por: Gopinath, S., et al.
Publicado: (2012)

Stimulation of Angiotensin Converting Enzyme 2: A Novel Treatment Strategy for Diabetic Nephropathy
por: Nomura, Haru, et al.
Publicado: (2022)

Association of polymorphisms in angiotensin-converting enzyme gene with gestational diabetes mellitus in Indian women
por: Aggarwal, Parul, et al.
Publicado: (2016)

GSTT1 Null Genotype Is a Risk Factor for Diabetic Retinopathy in Caucasians with Type 2 Diabetes, whereas GSTM1 Null Genotype Might Confer Protection against Retinopathy
por: Cilenšek, Ines, et al.
Publicado: (2012)

SNP rs2073618 of the Osteoprotegerin Gene Is Associated with Diabetic Retinopathy in Slovenian Patients with Type 2 Diabetes
por: Mankoč Ramuš, Sara, et al.
Publicado: (2013)

Investigation of angiotensin-1 converting enzyme 2 gene (G8790A) polymorphism in patients of type 2 diabetes mellitus with diabetic nephropathy in Pakistani population
por: Younas, Hooria, et al.
Publicado: (2022)

Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice
por: Nadarajah, Renisha, et al.
Publicado: (2012)

Weight loss for reduction of proteinuria in diabetic nephropathy: Comparison with angiotensin-converting enzyme inhibitor therapy
por: Patil, M. R., et al.
Publicado: (2013)

Effects of adding tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy
por: Fang, Jin-Ying, et al.
Publicado: (2020)

Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in The Netherlands – A Markov Model
por: Adarkwah, Charles Christian, et al.
Publicado: (2011)

Effect of rs4646994 polymorphism of angiotensin-converting enzyme on the risk of nonischemic cardiomyopathy
por: Shen, Jinsheng, et al.
Publicado: (2021)

Association between Angiotensin-Converting Enzyme-Insertion/Deletion Polymorphism and Diabetes Mellitus-2 in Saudi Population
por: Habibullah, Mahmoud, et al.
Publicado: (2021)

Association of Angiotensin-Converting Enzyme Gene Polymorphisms and Nephropathy in Diabetic Patients at a Tertiary Care Centre in South India
por: Wyawahare, Mukta, et al.
Publicado: (2017)

Reduction of microalbuminuria in type-2 diabetes mellitus with angiotensin-converting enzyme inhibitor alone and with cilnidipine
por: Singh, V. K., et al.
Publicado: (2015)

PECAM-1 gene polymorphism (rs668) and subclinical markers of carotid atherosclerosis in patients with type 2 diabetes mellitus
por: Popović, D, et al.
Publicado: (2016)

Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review
por: Huang, Yunyu, et al.
Publicado: (2014)

Combination therapy with an angiotensin‐converting‐enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy
por: Nakamura, Akihiko, et al.
Publicado: (2012)

Association of the ACE rs4646994 and rs4341 polymorphisms with the progression of carotid atherosclerosis in slovenian patients with type 2 diabetes mellitus
por: Merlo, S, et al.
Publicado: (2016)

Impact of Angiotensin Converting Enzyme Inhibitor versus Angiotensin Receptor Blocker on Incidence of New-Onset Diabetes Mellitus in Asians
por: Park, Ji Young, et al.
Publicado: (2016)

Genetic Association Between CD143 rs4340 Polymorphism and Pneumonia risk: A Meta Analysis
por: Wang, Hong, et al.
Publicado: (2015)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Polymorphism rs5498 of the ICAM-1 gene affects the progression of carotid atherosclerosis in patients with type 2 diabetes mellitus
por: Popović, Dražen, et al.
Publicado: (2016)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Comparing the Efficacy of Angiotensin Converting Enzyme Inhibitors with Calcium Channel Blockers on the Treatment of Diabetic Nephropathy: A Meta-Analysis
por: ZHANG, Zhaowei, et al.
Publicado: (2019)

Angiotensin-converting Enzyme Genetic Polymorphism
por: Wiwanitkit, Somsri, et al.
Publicado: (2014)

Simple Cystatin C Formula for Estimation of Glomerular Filtration Rate in Overweight Patients with Diabetes Mellitus Type 2 and Chronic Kidney Disease
por: Bevc, Sebastjan, et al.
Publicado: (2012)

Angiotensin-Converting Enzyme Genotype and Peripheral Arterial Disease in Diabetic Patients
por: Tseng, Chin-Hsiao, et al.
Publicado: (2012)

Efficacy of Administration of an Angiotensin Converting Enzyme Inhibitor for Two Years on Autonomic and Peripheral Neuropathy in Patients with Diabetes Mellitus
por: Didangelos, Triantafyllos, et al.
Publicado: (2017)

Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events in patients with diabetes and overt nephropathy: a meta-analysis of randomised controlled trials
por: Shunan, Fan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0s4uad772aqmtkvbq5oe9mqqvq